Literature DB >> 21559747

Prevalence of horB gene among the Helicobacter pylori strains isolated from dyspeptic patients: first report from Iran.

Tarang Taghvaei1, Amin Talebi Bezmin Abadi, Ali Ghasemzadeh, Behnam Kalali Naderi, Ashraf Mohabbati Mobarez.   

Abstract

Helicobacter pylori (H. pylori) is globally accepted as an important cause of gastritis in human, and evidence strongly shows an etiological role for H. pylori in gastric cancer and peptic ulceration. In this study, we determined the relationship between digestive diseases and the horB gene of H. pylori infection. Fresh antral biopsy specimens were obtained from 140 dyspeptic patients (67 men and 73 women; mean age 41.5, aged 19-63 years). They were examined for presence of the horB gene of H. pylori clinical isolates. Bacterial DNA content was extracted directly from the antral biopsy. Statistical analysis was performed with SPSS version 16.0. Prevalence of the horB gene in H. pylori isolated from patients with gastric cancer, gastric ulcer, gastritis and duodenal ulcer is (5/32) 15.6%, (4/25) 16%, (30/43) 70%, and (9/40) 22.5%, respectively. No significant relationship is observed between age, pathologic findings and gender factors with respect to the four digestive diseases (P > 0.05). In our examination, a significant association was observed between a horB positive genotype of H. pylori and the occurrence of gastritis; in support of the protective theory. Studies with a higher sample size in different countries of the world should be conducted to obtain a thorough assessment as to whether horB has a role in the progress of gastritis (protective effect) or not. Further tests should be carried out to determine the exact role of horB in infection of H. pylori.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21559747     DOI: 10.1007/s11739-011-0614-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  24 in total

1.  Molecular characterization of a flagellar export locus of Helicobacter pylori.

Authors:  S Porwollik; B Noonan; P W O'Toole
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  The complete genome sequence of the gastric pathogen Helicobacter pylori.

Authors:  J F Tomb; O White; A R Kerlavage; R A Clayton; G G Sutton; R D Fleischmann; K A Ketchum; H P Klenk; S Gill; B A Dougherty; K Nelson; J Quackenbush; L Zhou; E F Kirkness; S Peterson; B Loftus; D Richardson; R Dodson; H G Khalak; A Glodek; K McKenney; L M Fitzegerald; N Lee; M D Adams; E K Hickey; D E Berg; J D Gocayne; T R Utterback; J D Peterson; J M Kelley; M D Cotton; J M Weidman; C Fujii; C Bowman; L Watthey; E Wallin; W S Hayes; M Borodovsky; P D Karp; H O Smith; C M Fraser; J C Venter
Journal:  Nature       Date:  1997-08-07       Impact factor: 49.962

3.  Conservation, localization and expression of HopZ, a protein involved in adhesion of Helicobacter pylori.

Authors:  B Peck; M Ortkamp; K D Diehl; E Hundt; B Knapp
Journal:  Nucleic Acids Res       Date:  1999-08-15       Impact factor: 16.971

Review 4.  Pathogenesis of Helicobacter pylori infection.

Authors:  Daniela Basso; Mario Plebani; Johannes G Kusters
Journal:  Helicobacter       Date:  2010-09       Impact factor: 5.753

5.  Oral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticles.

Authors:  S Y Kim; H J Doh; M H Jang; Y J Ha; S I Chung; H J Park
Journal:  Helicobacter       Date:  1999-03       Impact factor: 5.753

6.  Low frequency of cagA-positive Helicobacter pylori strains isolated from Iranian patients with MALT lymphoma.

Authors:  Amin Talebi Bezmin Abadi; Ali Ghasemzadeh; Ashraf Mohabati Mobarez
Journal:  Intern Emerg Med       Date:  2011-04-02       Impact factor: 3.397

7.  Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran.

Authors:  Amin Talebi Bezmin Abadi; Ali Ghasemzadeh; Tarang Taghvaei; Ashraf Mohabbati Mobarez
Journal:  Intern Emerg Med       Date:  2011-03-25       Impact factor: 3.397

8.  Functional expression in Escherichia coli and membrane topology of porin HopE, a member of a large family of conserved proteins in Helicobacter pylori.

Authors:  J Bina; M Bains; R E Hancock
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

Review 9.  Gastric cancer in Iran: epidemiology and risk factors.

Authors:  Reza Malekzadeh; Mohammad H Derakhshan; Zinab Malekzadeh
Journal:  Arch Iran Med       Date:  2009-11       Impact factor: 1.354

Review 10.  Helicobacter pylori persistence: biology and disease.

Authors:  Martin J Blaser; John C Atherton
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

View more
  7 in total

1.  High Prevalence of Helicobacter pylori hopQ II Genotype Isolated from Iranian Patients with Gastroduodenal Disorders.

Authors:  Amin Talebi Bezmin Abadi; Ashraf Mohabbati Mobarez
Journal:  J Pathog       Date:  2014-02-10

Review 2.  Helicobacter pylori: Emergence of a Superbug.

Authors:  Amin Talebi Bezmin Abadi
Journal:  Front Med (Lausanne)       Date:  2014-10-14

Review 3.  Role of dupA in virulence of Helicobacter pylori.

Authors:  Amin Talebi Bezmin Abadi; Guillermo Perez-Perez
Journal:  World J Gastroenterol       Date:  2016-12-14       Impact factor: 5.742

Review 4.  Diagnosis of Helicobacter pylori Using Invasive and Noninvasive Approaches.

Authors:  Amin Talebi Bezmin Abadi
Journal:  J Pathog       Date:  2018-05-22

5.  Adding diclofenac to Helicobacter pylori eradication regimen.

Authors:  Mohammad Hasan Emami; Akbar Arjmandpour; Hamed Daghaghzadeh; Hojatollah Rahimi; Ali Toghiani; Peyman Adibi
Journal:  Adv Biomed Res       Date:  2015-07-27

6.  Clinical relevance of the cagA, tnpA and tnpB genes in Helicobacter pylori.

Authors:  Amin Talebi Bezmin Abadi; Ashraf Mohhabati Mobarez; Marc J M Bonten; Jaap A Wagenaar; Johannes G Kusters
Journal:  BMC Gastroenterol       Date:  2014-02-19       Impact factor: 3.067

7.  Relationship between the iceA gene of Helicobacter pylori and clinical outcomes.

Authors:  Xiaojun Huang; Zhaomin Deng; Qiang Zhang; Wanyi Li; Baoning Wang; Mingyuan Li
Journal:  Ther Clin Risk Manag       Date:  2016-07-06       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.